Malaria and Sickle Cell Disease Treatment Market Worth $29.17 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
November 03, 2023 08:33 ET | The Insight Partners
Pune, India, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Sickle cell disease (SCD) is the most common inherited blood disorder that affects the red blood cells. Treatments for SCD can relieve pain and help...
Novel Malaria Drug Discovery Presented at the ASTMH Tropical Medicine Meeting by Ocean Biomedical’s Scientific Co-founder, Dr. Jake Kurtis, unveiling the potential for a new class of Antimalarial Drugs.
November 01, 2022 09:15 ET | Aesther Healthcare Acquisition Corp.
• Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to be listed on NASDAQ under the symbol,...
Malaria Treatment Market to Outstrip $2,126.42 Million by 2027 Growing Sturdy at 4.4% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
April 21, 2021 08:00 ET | The Insight Partners
Pune, India., April 21, 2021 (GLOBE NEWSWIRE) -- Malaria Treatment Market: Key InsightsAccording to our new research study on “Malaria Treatment Market to 2027 – Global Analysis and Forecast – by...
logo long.jpg
Global Antiparasitic Drugs market to surpass US$ 10,842.7 million by 2027, Says CMI
April 24, 2020 11:02 ET | CMI
SEATTLE, April 24, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global antiparasitic drugs market was valued at US$ 7,227.9 million in 2019 and is expected to exhibit a CAGR...